Taylor Farms Voluntarily Recalls Fresh Jalapeños Over Salmonella Concerns
Taylor Farms recalls ready-to-eat foods and jalapeño products over salmonella concerns.
42 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 2 news categories, from Jun 23, 2026 through Aug 11, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
Taylor Farms recalls ready-to-eat foods and jalapeño products over salmonella concerns.
The first mRNA-based influenza vaccine has received federal approval in the United States.
The FDA has issued a nationwide recall of levothyroxine sodium tablets due to the drug being described as subpotent.
Capricor Therapeutics shares are plummeting after FDA staff disputed the company's claims of Phase 3 success for its DMD cell therapy.
Capricor Therapeutics shares have plunged after FDA staff raised concerns regarding the efficacy and data of its Duchenne heart disease therapy.
Compounded GLP-1 weight‑loss drugs face mounting scrutiny as doctors and regulators flag safety concerns.
Patients aged six and older now have access to SIMTRIYO, the first new-class ADHD medication approved by the FDA in decades.
A July 2026 Cyclospora scare is reshaping menus, boosting local produce sales and testing public trust in the FDA.
Eli Lilly is planning a Q1 2027 FDA application for retatrutide following new data on weight loss and A1C improvements.
Taylor Farms faces a class-action lawsuit and operational shutdowns following a cyclosporiasis outbreak linked to its products.
Brooklyn Roasting Company is recalling over 3,000 gallons of cold brew concentrate sold in New York and New Jersey due to a botulism risk.
The FDA has approved the first oral medication designed to replace injectable treatments for high cholesterol.
Amy’s Kitchen has recalled over 184,000 cans of vegan lentil soup across the U.S. due to a can defect that poses a spoilage risk.
An FDA panel vote on peptides has sparked concerns regarding a potential surge in prescriptions for these compounds.
An egg-linked salmonella outbreak has triggered a recall of 1.6 million eggs following reports of 98 illnesses across 17 states.
A former FDA commissioner warns that the federal response to a multi-state Cyclospora outbreak is approaching a 'catastrophic' level.
FDA advisory committees have issued split decisions on the legal path for peptides amid high-profile advocacy for their wider availability.
An FDA advisory panel review of seven peptides is sparking a debate over longevity medicine, public health risks, and potential multibillion-dollar markets.
Federal health officials investigate multiple clusters of cyclosporiasis, with iceberg lettuce identified as the likely cause.
The FDA continues to target Taylor Farms lettuce as the source of a Cyclospora outbreak despite a retracted positive test result.
FDA approval of an at-home subcutaneous injection for Leqembi marks a shift in the delivery of early Alzheimer's disease treatment.
A multi-state iceberg lettuce recall is underway after the FDA linked a cyclosporis parasite outbreak to Taylor Farms.
Iceberg lettuce is being recalled across 27 states following a cyclosporiasis outbreak linked to Taylor Farms.
General Mills is recalling 730,000 Pillsbury bread rolls across 18 states due to potential glass contamination.
New brain-shuttle biologics are overcoming the blood-brain barrier to deliver critical treatments for Alzheimer's and cancer.
A multistate cyclospora parasite outbreak has been linked to iceberg lettuce supplied by Taylor Farms to Taco Bell stores.
Taco Bell has removed lettuce from its U.S. menus following links to a cyclosporiasis outbreak traced to supplier Taylor Farms.
The FDA has approved Lipfendra, the first-of-its-kind oral PCSK9 inhibitor designed to significantly reduce cholesterol levels.
Sanofi's Sarclisa becomes the first cancer drug approved by the FDA for delivery via an on-body injector for multiple myeloma.
The FDA has issued a nationwide recall of 2.5 million bottles of steroid eye drops due to contamination concerns.
The FDA has approved Vera Therapeutics' drug Trutakna to treat primary IgA nephropathy, sparking a new market competition for kidney disease treatments.
Tobacco companies are racing to capitalize on the surging popularity of Zyn and other smoke-free alternatives.
The U.S. sunscreen market is shifting toward clinical necessity following the FDA's first approval of a new active ingredient in decades.
The FDA has upgraded a potato chip recall involving brands like Utz Zapp's and Dirty to Class I, its highest risk level, due to salmonella concerns.
The FDA has granted Philip Morris permission to market ZYN nicotine pouches as a safer, lower-risk alternative to cigarettes.
The FDA has launched a new initiative to accelerate the review process for new pharmaceutical manufacturing facilities.
Major online retailers are recalling TNVitamins moringa powder supplements nationwide due to potential salmonella contamination.
Nearly 1 million bottles of heart and kidney medications have been recalled nationwide due to the discovery of foreign substances on the tablets.
The FDA has classified a massive recall of Utz potato chip brands as a Class I risk due to potential salmonella contamination.
The FDA has granted broad first-line approval for Gilead's Trodelvy, signaling a shift away from traditional chemotherapy for aggressive breast cancer.
Wearable technology is shifting from general fitness tracking toward clinical healthcare integration and Medicare eligibility.
The U.S. Department of Health and Human Services is launching a department-wide effort to accelerate clinical trials and restore American leadership in medical research.